Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.
Wang L, Liu X, Liu Z, Wang Y, Fan M, Yin J, Zhang Y, Ma Y, Luo J, Li R, Zhao X, Zhang P, Zhao L, Fan J, Chen Y, Lu W, Song X.
Wang L, et al. Among authors: zhang p, zhang y.
Sci Rep. 2022 Jan 7;12(1):192. doi: 10.1038/s41598-021-03946-w.
Sci Rep. 2022.
PMID: 34996995
Free PMC article.